Keywords: submits, maa, doripenem, emea, belgium, janssen-cilag, international

J&J submits MAA for doripenem to EMEA

Article | 30 July 2007

Print This

Belgium's Janssen-Cilag International NV, a unit of US health care major Johnson & Johnson, says that the European Medicines Agency (EMEA) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in